# Public Health Emergency: SOLIDARITY TRIAL Philippines

> **NCT05024006** · NA · COMPLETED · sponsor: **University of the Philippines** · enrollment: 1314 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Remdesivir
- **DRUG:** Hydroxychloroquine
- **DRUG:** Lopinavir / Ritonavir
- **DRUG:** Interferon beta-1a
- **DRUG:** Acalabrutinib

## Key facts

- **NCT ID:** NCT05024006
- **Lead sponsor:** University of the Philippines
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-23
- **Primary completion:** 2021-04-17
- **Final completion:** 2021-04-17
- **Target enrollment:** 1314 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05024006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05024006, "Public Health Emergency: SOLIDARITY TRIAL Philippines". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05024006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*